High Tumor Mutation Burden and DNA Repair Gene Mutations are Associated with Primary Resistance to Crizotinib in ALK-Rearranged Lung Cancer

BACKGROUND: About 20% of patients with ALK-rearranged non-small cell lung cancer (NSCLC) develop acquired resistance to tyrosine kinase inhibitor (TKI) during the first 6 months. This study aimed to examine the molecular mechanisms of early TKI resistance and prognosis in ALK-rearranged NSCLC. METHO...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiao, Dakai, Deng, Qiuhua, He, Dongyun, Huang, Ying, Liang, Wenchi, Wang, Fengnan, Yang, Haihong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8450189/
https://www.ncbi.nlm.nih.gov/pubmed/34552337
http://dx.doi.org/10.2147/OTT.S325443

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8450189/
https://www.ncbi.nlm.nih.gov/pubmed/34552337
http://dx.doi.org/10.2147/OTT.S325443

Ejemplares similares